NCT05730400

Brief Summary

Aim : The aim of present study was to evaluate BMAC/bovine graft utilization in Sinus membrane augmentation on bone quality and quantity. Methodology: sixteen patients suffering from atrophic posterior maxilla with sinus pneumatization were randomly divided into two equal groups: study group: the sinus membrane was elevated with BMAC/bovine graft whereas the control group recieved bovine graft only for sinus floor augmentation. All patients will be evaluated at 1 week, 4 months to measure bone height and bone core biopsy for histological assessment at 4 months during implant placement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 26, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 15, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

January 26, 2023

Last Update Submit

February 5, 2024

Conditions

Keywords

Bone marrowSinus augmentationSinus lift

Outcome Measures

Primary Outcomes (1)

  • Histological assessment

    Histological assessment of core biopsy obtained at time of implant placement for percentage of new bone formation and residual graft

    After 4 months of surgery

Secondary Outcomes (2)

  • Implant stability

    After 4 months of surgery

  • Bone gain

    Preoperative, immediate and 4 months Postoperative

Study Arms (2)

BMAC/bovine graft

ACTIVE COMPARATOR

Bone marrow aspirate concentrate loaded on bovine graft (Tutogen Medical GmbH, Neunkirchen am Brand, Germany, 1- 2mm particle size) utilization for sinus floor augmentation with residual alveolar bone height less than 5 mm, 1st arm

Drug: BMAC loaded on bovine graft

Bovine graft group

ACTIVE COMPARATOR

bovine graft utilization for sinus floor augmentation with residual alveolar bone height less than 5 mm, 2nd arm

Drug: Bovine graft only

Interventions

Bone marrow aspirate concentrate loaded on bovine graft for sinus floor augmentation

Also known as: Bone marrow aspirate concentrate loaded on bovine graft
BMAC/bovine graft

Bovine graft only for sinus floor augmentation

Also known as: Unloaded bovine graft
Bovine graft group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with missing upper posterior teeth and atrophic posterior maxilla with a residual bone height ranging from 4 to 6 mm
  • Patients who has as deficient as 4 mm vertical bone height in posterior maxilla that need bone augmentation before delayed implant placement.
  • Highly motivated patients

You may not qualify if:

  • Patients suffering from any systemic disease or those under any medication that may interfere with normal bone healing.
  • Patients suffering from any sinus pathosis.
  • Patients with conditions that could potentially compromise BM quality, previous BMA, or acute illness.
  • Heavy smoker (\> 20 cigarettes daily)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, department of oral and Maxillofacial Surgery

Cairo, 02, Egypt

Location

Study Officials

  • Maha Hakam, Phd

    Professor at Faculty of Dentistry Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of oral and Maxillofacial Surgery

Study Record Dates

First Submitted

January 26, 2023

First Posted

February 15, 2023

Study Start

October 30, 2022

Primary Completion

August 30, 2023

Study Completion

September 15, 2023

Last Updated

February 6, 2024

Record last verified: 2024-02

Locations